Management of Worsening Septic Shock

Immediate Priority Actions

The Surviving Sepsis Campaign recommends immediate reassessment for source control, adding empiric coverage for additional resistant pathogens, optimizing antimicrobial dosing strategies, and considering adjunctive therapies while obtaining urgent cultures to guide de-escalation, as patients with worsening septic shock despite polymyxin B and meropenem require prompt intervention 1, 2, 3
Identify and eliminate any uncontrolled infectious source within 12 hours, as this is the single most critical intervention when patients deteriorate on appropriate antibiotics, according to the Intensive Care Medicine guidelines 2, 3
Obtain urgent imaging to identify drainable collections, undrained abscesses, infected devices, or necrotic tissue, as recommended by Critical Care Medicine 4, 2
Remove any intravascular access devices that could be infected and replace them at new sites, as suggested by Intensive Care Medicine 2, 3
Consider surgical consultation for any potentially drainable focus, choosing the least physiologically invasive intervention, according to Intensive Care Medicine 3

Add vancomycin immediately to cover MRSA and resistant gram-positive organisms, as recommended by Praxis Medical Insights 5
Consider adding an aminoglycoside or fluoroquinolone for synergistic gram-negative coverage, as the Surviving Sepsis Campaign specifically recommends combination therapy for septic shock with difficult-to-treat multidrug-resistant pathogens like Pseudomonas and Acinetobacter 1, 2, 6

Draw at least two sets of blood cultures before adding new antibiotics, as recommended by Critical Care Medicine and Intensive Care Medicine 1, 2
Obtain site-specific cultures, such as respiratory, urine, wound, or any other potential source, as suggested by Praxis Medical Insights 5
Consider fungal cultures if the patient has been on broad-spectrum antibiotics, has central lines, or is immunocompromised, according to Critical Care Medicine and Intensive Care Medicine 4, 2

Reassess antimicrobial regimen daily for potential de-escalation once culture results return, as recommended by Critical Care Medicine, Intensive Care Medicine, and the Surviving Sepsis Campaign 1, 2, 3
Plan for 7-10 days total duration for most serious infections, though longer courses may be needed with slow clinical response, undrainable foci, or S. aureus bacteremia, according to Critical Care Medicine and Intensive Care Medicine 1, 3
De-escalate combination therapy within 3-5 days once clinical improvement occurs or sensitivities are known, as recommended by Critical Care Medicine and Intensive Care Medicine 1, 2

Failure to identify and control the source is the most common reason for antibiotic failure in septic shock, as stated by Intensive Care Medicine 2, 3
Inadequate MRSA coverage in patients already on broad gram-negative therapy is frequently overlooked, according to Praxis Medical Insights 5
Delayed addition of appropriate coverage can increase mortality, so empiric broadening should occur immediately while awaiting cultures, as recommended by Critical Care Medicine and Praxis Medical Insights 8, 5
Prolonged broad-spectrum therapy without de-escalation increases risk of C. difficile, resistant organisms, and fungal superinfection, according to Critical Care Medicine 6, 7